Bogga ugu weyn CBD MHRA waxay ansixisay Epidyolex (cannabidiol) si loogu daweeyo isku -buufinta tuubada caagga ah

MHRA waxay ansixisay Epidyolex (cannabidiol) si loogu daweeyo isku -buufinta tuubada caagga ah

albaabka Ties Inc.

2021-08-17-MHRA waxay ansixisay Epidyolex (cannabidiol) daawaynta kakan sclerosis

GW Pharmaceuticals waxay heshay oggolaansho Epidyolex®(cannabidiol) ee daawaynta werarada la xidhiidha isku-dhafka xuubka sclerosis (TSC) gudaha UK.

GW Pharmaceuticals, oo hadda qayb ka ah Jazz Pharmaceuticals, ayaa ku dhawaaqday in Hay'adda Nidaaminta Daawada iyo Caafimaadka UK (MHRA) ay ansixisay tilmaame cusub oo loogu talagalay Epidyolex® (cannabidiol); sida daaweynta iskuxiran ee miyir-beelka ee la xidhiidha dhismaha tuberous sclerosis (TSC) ee bukaanada da'doodu tahay laba sano iyo ka weyn. Complex tuberous Sclerosis (TSC) waa xaalad la iska dhaxlo oo ay burooyin aan fiicneyn ay ka soo baxaan meelo kala duwan oo jirka ah.

Cannabidiol loogu talagalay daaweynta burooyinka iyo suuxdinta

"Waxaan ku faraxsanahay go'aanka MHRA ee tilmaantan cusub, oo u taagan tallaabo weyn oo horay loogu qaaday bukaannada TSC ee UK," ayuu yiri Chris Tovey, Madaxweyne Ku -xigeenka Fulinta ee Jazz Pharmaceuticals.
Epidyolex, oo ah dawadii ugu horreysay ee ku saleysan xashiishadda, ayaa waxaa oggolaaday Maamulka Cuntada iyo Dawooyinka ee Mareykanka (FDA) si loogu isticmaalo Mareykanka iyo Guddiga Yurub (EC) si loogu isticmaalo Midowga Yurub (EU). Waa xal afka laga qaato oo ay ku jirto cannabidiol oo aad loo sifeeyay (CBD). Wakaaladda Daawooyinka Yurub (EMA) ayaa u ogolaatay daawada loogu talagalay daawaynta qalalka ee la xidhiidha LGS, Dravet syndrome iyo TSC.

Akhri wax dheeraad ah europeanpharmaceuticalreview.com (Source, EN)

Maqaallo la xidhiidha

Faallo ka tag